title: Intracoronary drug delivery: mechanically too rough, pharmacologically too weak?
authors.forename: P
authors.initials: P
authors.lastname: Widimský
mesh_terms: D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control* / Q000628:therapy; D003331:Coronary Vessels; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D017762:Nadroparin / Q000008:administration & dosage*; D018570:Risk Assessment; D055502:Secondary Prevention; D012680:Sensitivity and Specificity; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D017762:Nadroparin